Morgan Stanley’s Calvert US Select Equity ETF CVSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-166,602
Closed -$10.8M 8132
2025
Q1
$10.8M Sell
166,602
-73,000
-30% -$4.94M ﹤0.01% 3269
2024
Q4
$16.2M Sell
239,602
-10,000
-4% -$693K ﹤0.01% 2966
2024
Q3
$17.1M Sell
249,602
-150,398
-38% -$9.88M ﹤0.01% 2947
2024
Q2
$25.7M Hold
400,000
﹤0.01% 2394
2024
Q1
$25.5M Sell
400,000
-400,000
-50% -$24.1M ﹤0.01% 2426
2023
Q4
$46M Buy
800,000
+400,000
+100% +$21.3M ﹤0.01% 2549
2023
Q3
$20.4M Hold
400,000
﹤0.01% 2424
2023
Q2
$21.6M Hold
400,000
﹤0.01% 2398
2023
Q1
$20.2M Buy
+400,000
New +$19.9M ﹤0.01% 2404

Other funds holding CVSE

Morgan Stanley's CVSE Position: Q2 2025 in Review

Morgan Stanley sold out of Calvert US Select Equity ETF (CVSE) in Q2 2025, closing a stake of 166,602 shares — an estimated $10.8M sold.

Morgan Stanley first reported a position in CVSE in Q1 2023 and held it in 9 quarters. The position peaked at $46M in Q4 2023. 10 funds tracked by Wall St. Rank hold CVSE as of Q2 2025.

  • Morgan Stanley reported no remaining Calvert US Select Equity ETF position as of Q2 2025 after selling out during the quarter.
  • Morgan Stanley sold 166,602 Calvert US Select Equity ETF shares in Q2 2025, an estimated $10.8M.
  • Morgan Stanley first reported a position in Calvert US Select Equity ETF in Q1 2023 and held it in 9 quarters.
  • Morgan Stanley's Calvert US Select Equity ETF position peaked at $46M in Q4 2023.
  • 10 funds tracked by Wall St. Rank held Calvert US Select Equity ETF as of Q2 2025.

Based on Morgan Stanley's 13F filing for Q2 2025, filed 15 Aug 2025.